SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001023024-05-000004
Filing Date
2005-04-29
Accepted
2005-04-29 16:17:13
Documents
2
Period of Report
2005-04-29
Effectiveness Date
2005-04-29

Document Format Files

Seq Description Document Type Size
1 BIOSANTE 2005 PROXY STATEMENT proxy.htm DEF 14A 499735
2 BIOSANTE LOGO biosantelogo6.jpg GRAPHIC 12999
  Complete submission text file 0001023024-05-000004.txt   519359
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 05786213
SIC: 2836 Biological Products, (No Diagnostic Substances)